Literature DB >> 29313857

Extracapsular lymph node involvement after neoadjuvant chemoradiation in esophageal carcinoma: how to interpret?

Lieven P Depypere1, Philippe R Nafteux1.   

Abstract

Entities:  

Year:  2017        PMID： 29313857      PMCID： PMC5757018          DOI： 10.21037/jtd.2017.10.163

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  8 in total

Review 1.  Predicting extracapsular spread of head and neck cancers using different imaging techniques: a systematic review and meta-analysis.

Authors:  Z Su; Z Duan; W Pan; C Wu; Y Jia; B Han; C Li
Journal:  Int J Oral Maxillofac Surg       Date:  2015-12-23       Impact factor: 2.789

2.  An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.

Authors:  Weining Wang; Weng Khong Lim; Hui Sun Leong; Fui Teen Chong; Tony K H Lim; Daniel S W Tan; Bin Tean Teh; N Gopalakrishna Iyer
Journal:  Oral Oncol       Date:  2015-01-02       Impact factor: 5.337

3.  Extranodal extension of nodal metastasis is the main prognostic moderator in squamous cell carcinoma of the esophagus after neoadjuvant chemoradiotherapy.

Authors:  Claudio Luchini; Nicola Veronese
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

4.  Extracapsular lymph node involvement in patients with esophageal cancer treated with neoadjuvant chemoradiation therapy followed by surgery: the closer you look, the less you see.

Authors:  Yin-Kai Chao
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

5.  Prognostic significance of a new grading system of lymph node morphology after neoadjuvant radiochemotherapy for esophageal cancer.

Authors:  Elfriede Bollschweiler; Arnulf H Hölscher; Ralf Metzger; Sarah Besch; Stefan P Mönig; Stephan E Baldus; Uta Drebber
Journal:  Ann Thorac Surg       Date:  2011-12       Impact factor: 4.330

6.  Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.

Authors:  Dylan R Nieman; Christian G Peyre; Thomas J Watson; Wenqing Cao; Michael D Lunt; Michal J Lada; Michelle S Han; Carolyn E Jones; Jeffrey H Peters
Journal:  Ann Thorac Surg       Date:  2014-11-05       Impact factor: 4.330

7.  Impact of Extracapsular Lymph Node Involvement After Neoadjuvant Chemoradiation Therapy Followed by Surgery in Carcinoma of the Esophagus: A Multicenter Study.

Authors:  Lieven P Depypere; Johnny Moons; Christophe Mariette; Xavier B D'Journo; Pascal A Thomas; Arnulf H Hölscher; Elfriede Bollschweiler; Mark I van Berge-Henegouwen; Jan J B Van Lanschot; Toni E M R Lerut; Philippe R Nafteux
Journal:  Ann Surg       Date:  2018-12       Impact factor: 12.969

8.  International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems.

Authors:  Philippe R Nafteux; Antoon M Lerut; Johnny Moons; Arnulf H Hölscher; Elfriede Bollschweiler; Mark I van Berge Henegouwen; Sjoerd M Lagarde; Jan J van Lanschot; Mathieu Messager; Christophe Mariette; Xavier B D'Journo; Pascal A Thomas; Paul R De Leyn
Journal:  Ann Surg       Date:  2015-11       Impact factor: 12.969
  8 in total
  1 in total

1.  Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinoma.

Authors:  Apostolos Kandilis; Carlos Bravo Iniguez; Hassan Khalil; Emanuele Mazzola; Michael T Jaklitsch; Scott J Swanson; Raphael Bueno; Jon O Wee
Journal:  JTCVS Open       Date:  2020-12-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.